A feasibility study of accelerated polychemotherapy with cisplatin, epidoxorubicin and cyclophosphamide (PEC) in advanced ovarian cancer.

por Pronzato, P., Bertelli, G., Vigani, A., Vaira, F.
Publicado 1996

Loss to follow-up in anti-HCV-positive patients in a Brazilian regional outpatient clinic

por Mendes, L.C., Ralla, S.M., Vigani, A.G.
Publicado 2016

Treatment of hepatitis C virus genotype 3 infection with direct-acting antiviral agents

por Zanaga, L.P., Miotto, N., Mendes, L.C., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016

Transient elastography and APRI score: looking at false positives and false negatives. Diagnostic performance and association to fibrosis staging in chronic hepatitis C

por Mendes, L.C., Ferreira, P.A., Miotto, N., Zanaga, L., Gonçales, E., Lazarini, M.S., Gonçales, F.L., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016

Survival benefits of interferon-based therapy in patients with recurrent hepatitis C after orthotopic liver transplantation

por Zanaga, L.P., Vigani, A.G., Angerami, R.N., Giorgetti, A., Escanhoela, C.A.F., Ataíde, E.C., Boin, I.F.S.F., Stucchi, R.S.B.
Publicado 2017

1725P Development and validation of telematic follow-up for cancer patients during the COVID-19 outbreak

por Pastorino, A., Negru, M.E., Vigani, A., Vaira, F., Tognoni, A., Ferrari, A., Ricci, I., Rondini, M., Olcese, F., Milano, A., Cozzani, F., Aschele, C.
Publicado 2020

Predictors of early treatment discontinuation and severe anemia in a Brazilian cohort of hepatitis C patients treated with first-generation protease inhibitors

por Miotto, N., Mendes, L.C., Zanaga, L.P., Goncales, E.S.L., Lazarini, M.S.K., Pedro, M.N., Goncales, F.L., Stucchi, R.S.B., Vigani, A.G.
Publicado 2016